Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Replicating predictive serum correlates of greater translocator protein distribution volume in brain.

Attwells S, Setiawan E, Wilson AA, Rusjan PM, Miler L, Xu C, Hutton C, Husain MI, Kish S, Vasdev N, Houle S, Meyer JH.

Neuropsychopharmacology. 2019 Nov 4. doi: 10.1038/s41386-019-0561-y. [Epub ahead of print]

PMID:
31683271
2.

In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

Da Silva T, Hafizi S, Watts JJ, Weickert CS, Meyer JH, Houle S, Rusjan P, Mizrahi R.

JAMA Psychiatry. 2019 Sep 18. doi: 10.1001/jamapsychiatry.2019.2516. [Epub ahead of print] Erratum in: JAMA Psychiatry. 2019 Oct 16;:.

PMID:
31532458
3.

Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.

Schifani C, Pruessner J, Tseng HH, Rao N, Tagore A, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Addict Biol. 2019 Aug 6:e12812. doi: 10.1111/adb.12812. [Epub ahead of print]

PMID:
31389139
4.

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP.

Mol Neurobiol. 2019 Aug 5. doi: 10.1007/s12035-019-01714-6. [Epub ahead of print]

PMID:
31385228
5.

Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [11C]FLB457 positron emission tomography study.

Tagore A, Schifani C, Rao N, Tseng HH, Zakzanis KK, Rusjan PM, Houle S, Mizrahi R.

Eur Neuropsychopharmacol. 2019 Sep;29(9):1023-1032. doi: 10.1016/j.euroneuro.2019.06.004. Epub 2019 Jul 24.

PMID:
31351843
6.

Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ.

J Cereb Blood Flow Metab. 2019 Jun 20:271678X19858003. doi: 10.1177/0271678X19858003. [Epub ahead of print]

PMID:
31220997
7.

DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum.

Valli M, Cho SS, Masellis M, Chen R, Rusjan P, Kim J, Koshimori Y, Mihaescu A, Strafella AP.

Mol Neurobiol. 2019 Sep;56(9):6512-6520. doi: 10.1007/s12035-019-1543-0. Epub 2019 Mar 8.

PMID:
30847741
8.

Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.

Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, Rajkowska G, Wang J, Bagby M, Mizrahi R, Varughese B, Houle S, Meyer JH.

JAMA Psychiatry. 2019 Jun 1;76(6):634-641. doi: 10.1001/jamapsychiatry.2019.0044. Erratum in: JAMA Psychiatry. 2019 Apr 10;:.

PMID:
30840042
9.

Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.

Schifani C, Hafizi S, Tseng HH, Gerritsen C, Kenk M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Schizophr Res. 2019 Nov;213:80-86. doi: 10.1016/j.schres.2018.10.008. Epub 2018 Nov 6.

PMID:
30409695
10.

GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.

Da Silva T, Hafizi S, Rusjan PM, Houle S, Wilson AA, Prce I, Sailasuta N, Mizrahi R.

J Psychiatry Neurosci. 2019 Mar 1;44(2):111-119. doi: 10.1503/jpn.170201.

11.

TSPO expression and brain structure in the psychosis spectrum.

Hafizi S, Guma E, Koppel A, Da Silva T, Kiang M, Houle S, Wilson AA, Rusjan PM, Chakravarty MM, Mizrahi R.

Brain Behav Immun. 2018 Nov;74:79-85. doi: 10.1016/j.bbi.2018.06.009. Epub 2018 Jun 12.

12.

Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.

Rao N, Northoff G, Tagore A, Rusjan P, Kenk M, Wilson A, Houle S, Strafella A, Remington G, Mizrahi R.

Schizophr Bull. 2019 Apr 25;45(3):670-679. doi: 10.1093/schbul/sby076.

PMID:
29878197
13.

Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.

Schifani C, Tseng HH, Kenk M, Tagore A, Kiang M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Brain. 2018 Jul 1;141(7):2213-2224. doi: 10.1093/brain/awy133.

14.

Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, Prce I, Wilson AA, Rusjan PM, Sailasuta N, Mizrahi R.

Neuropsychopharmacology. 2018 Jul;43(8):1700-1705. doi: 10.1038/s41386-018-0061-5. Epub 2018 Apr 13.

15.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

16.

Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.

Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Xu C, Sharma S, Kish S, Houle S, Meyer JH.

Lancet Psychiatry. 2018 Apr;5(4):339-347. doi: 10.1016/S2215-0366(18)30048-8. Epub 2018 Feb 26.

PMID:
29496589
17.

Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography.

Rusjan PM, Knezevic D, Boileau I, Tong J, Mizrahi R, Wilson AA, Houle S.

PLoS One. 2018 Feb 14;13(2):e0192410. doi: 10.1371/journal.pone.0192410. eCollection 2018.

18.

Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment.

Knezevic D, Verhoeff NPL, Hafizi S, Strafella AP, Graff-Guerrero A, Rajji T, Pollock BG, Houle S, Rusjan PM, Mizrahi R.

J Cereb Blood Flow Metab. 2018 Nov;38(11):1885-1895. doi: 10.1177/0271678X17741395. Epub 2017 Nov 14.

19.

Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.

Tseng HH, Watts JJ, Kiang M, Suridjan I, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Schizophr Bull. 2018 Apr 6;44(3):542-551. doi: 10.1093/schbul/sbx042.

20.

[18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP.

Coakeley S, Cho SS, Koshimori Y, Rusjan P, Ghadery C, Kim J, Lang AE, Houle S, Strafella AP.

Brain Struct Funct. 2018 Mar;223(2):589-595. doi: 10.1007/s00429-017-1507-y. Epub 2017 Sep 7.

PMID:
28884232
21.

Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH.

JAMA Psychiatry. 2017 Aug 1;74(8):833-840. doi: 10.1001/jamapsychiatry.2017.1567.

22.

Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.

Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I, Wilson AA, Houle S, Rusjan PM, Mizrahi R.

Neuropsychopharmacology. 2017 Dec;42(13):2474-2481. doi: 10.1038/npp.2017.111. Epub 2017 Jun 12.

23.

Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.

Mabrouk R, Strafella AP, Knezevic D, Ghadery C, Mizrahi R, Gharehgazlou A, Koshimori Y, Houle S, Rusjan P.

PLoS One. 2017 May 17;12(5):e0177785. doi: 10.1371/journal.pone.0177785. eCollection 2017.

24.

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Butcher NJ, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, Repetto GM, Fritsch R, Chow EWC, Masellis M, Strafella AP, Lang AE, Bassett AS.

Brain. 2017 May 1;140(5):1371-1383. doi: 10.1093/brain/awx053.

PMID:
28369257
25.

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.

Coakeley S, Cho SS, Koshimori Y, Rusjan P, Harris M, Ghadery C, Kim J, Lang AE, Wilson A, Houle S, Strafella AP.

J Cereb Blood Flow Metab. 2017 Sep;37(9):3150-3160. doi: 10.1177/0271678X16683695. Epub 2016 Dec 22.

26.

The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations.

Cho SS, Strafella AP, Duff-Canning S, Zurowski M, Vijverman AC, Bruno V, Aquino CC, Criaud M, Rusjan PM, Houle S, Fox SH.

Mov Disord Clin Pract. 2017 Jan 23;4(5):698-709. doi: 10.1002/mdc3.12466. eCollection 2017 Sep-Oct.

27.

Microglial activation in Parkinson's disease using [18F]-FEPPA.

Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP.

J Neuroinflammation. 2017 Jan 11;14(1):8. doi: 10.1186/s12974-016-0778-1.

28.

Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.

Egerton A, Howes OD, Houle S, McKenzie K, Valmaggia LR, Bagby MR, Tseng HH, Bloomfield MA, Kenk M, Bhattacharyya S, Suridjan I, Chaddock CA, Winton-Brown TT, Allen P, Rusjan P, Remington G, Meyer-Lindenberg A, McGuire PK, Mizrahi R.

Schizophr Bull. 2017 Mar 1;43(2):293-301. doi: 10.1093/schbul/sbw181.

29.

Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain.

Tong J, Mizrahi R, Houle S, Kish SJ, Boileau I, Nobrega J, Rusjan PM, Wilson AA.

J Cereb Blood Flow Metab. 2017 Nov;37(11):3635-3639. doi: 10.1177/0271678X16668890. Epub 2016 Oct 1.

30.

Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.

Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, Suridjan I, Wilson AA, Meyer JH, Remington G, Houle S, Rusjan PM, Mizrahi R.

Am J Psychiatry. 2017 Feb 1;174(2):118-124. doi: 10.1176/appi.ajp.2016.16020171. Epub 2016 Sep 9.

31.

Serotonin transporter binding is reduced in seasonal affective disorder following light therapy.

Tyrer AE, Levitan RD, Houle S, Wilson AA, Nobrega JN, Rusjan PM, Meyer JH.

Acta Psychiatr Scand. 2016 Nov;134(5):410-419. doi: 10.1111/acps.12632. Epub 2016 Aug 24.

PMID:
27553523
32.

Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ.

Neuropsychopharmacology. 2016 Dec;41(13):2994-3002. doi: 10.1038/npp.2016.108. Epub 2016 Jun 29.

33.

Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.

Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J.

Biol Psychiatry. 2016 Nov 1;80(9):691-701. doi: 10.1016/j.biopsych.2016.04.012. Epub 2016 Apr 25.

34.

D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.

Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I.

Neurology. 2016 Jan 19;86(3):224-30. doi: 10.1212/WNL.0000000000002285. Epub 2015 Dec 30.

35.

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

Koshimori Y, Ko JH, Mizrahi R, Rusjan P, Mabrouk R, Jacobs MF, Christopher L, Hamani C, Lang AE, Wilson AA, Houle S, Strafella AP.

PLoS One. 2015 Sep 18;10(9):e0138721. doi: 10.1371/journal.pone.0138721. eCollection 2015.

36.

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.

Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH.

Int J Neuropsychopharmacol. 2015 Aug 27;19(1). pii: pyv078. doi: 10.1093/ijnp/pyv078.

37.

Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.

Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1827-35. doi: 10.1038/jcbfm.2015.133. Epub 2015 Jun 17.

38.

The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.

Boileau I, Tyndale RF, Williams B, Mansouri E, Westwood DJ, Le Foll B, Rusjan PM, Mizrahi R, De Luca V, Zhou Q, Wilson AA, Houle S, Kish SJ, Tong J.

J Cereb Blood Flow Metab. 2015 Aug;35(8):1237-40. doi: 10.1038/jcbfm.2015.119. Epub 2015 Jun 3.

39.

Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex.

Harrison SJ, Tyrer AE, Levitan RD, Xu X, Houle S, Wilson AA, Nobrega JN, Rusjan PM, Meyer JH.

Acta Psychiatr Scand. 2015 Nov;132(5):379-88. doi: 10.1111/acps.12424. Epub 2015 Apr 17.

40.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.

Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18.

PMID:
25788222
41.

In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.

Suridjan I, Pollock BG, Verhoeff NP, Voineskos AN, Chow T, Rusjan PM, Lobaugh NJ, Houle S, Mulsant BH, Mizrahi R.

Mol Psychiatry. 2015 Dec;20(12):1579-87. doi: 10.1038/mp.2015.1. Epub 2015 Feb 24.

PMID:
25707397
42.

[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.

Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I.

Mov Disord. 2015 Feb;30(2):160-6. doi: 10.1002/mds.26135. Epub 2015 Jan 14.

PMID:
25641350
43.

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.

Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas PV, Houle S, Meyer JH.

JAMA Psychiatry. 2015 Mar;72(3):268-75. doi: 10.1001/jamapsychiatry.2014.2427.

44.

Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.

Mabrouk R, Rusjan PM, Mizrahi R, Jacobs MF, Koshimori Y, Houle S, Ko JH, Strafella AP.

PLoS One. 2014 Dec 30;9(12):e115768. doi: 10.1371/journal.pone.0115768. eCollection 2014.

45.

Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.

Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP.

Ann Neurol. 2015 Feb;77(2):269-80. doi: 10.1002/ana.24323. Epub 2014 Dec 30.

46.

Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.

Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J.

J Nucl Med. 2014 Dec;55(12):1993-7. doi: 10.2967/jnumed.114.146464. Epub 2014 Nov 20.

47.

Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.

Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, Meyer JH, Wilson AA, Houle S, Mizrahi R.

Schizophr Bull. 2015 Jan;41(1):85-93. doi: 10.1093/schbul/sbu157. Epub 2014 Nov 9.

48.

Investing in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewards.

Cho SS, Koshimori Y, Aminian K, Obeso I, Rusjan P, Lang AE, Daskalakis ZJ, Houle S, Strafella AP.

Neuropsychopharmacology. 2015 Feb;40(3):546-53. doi: 10.1038/npp.2014.211. Epub 2014 Aug 29.

49.

Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying.

Sacher J, Rekkas PV, Wilson AA, Houle S, Romano L, Hamidi J, Rusjan P, Fan I, Stewart DE, Meyer JH.

Neuropsychopharmacology. 2015 Jan;40(2):429-35. doi: 10.1038/npp.2014.190. Epub 2014 Jul 30.

50.

Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.

Suridjan I, Rusjan PM, Kenk M, Verhoeff NP, Voineskos AN, Rotenberg D, Wilson AA, Meyer JH, Houle S, Mizrahi R.

Synapse. 2014 Nov;68(11):536-47. doi: 10.1002/syn.21765. Epub 2014 Jul 28.

PMID:
25043159

Supplemental Content

Loading ...
Support Center